Warning letter
Braintree Laboratories Inc [ARCHIVED]: warning letter of May 10, 2010
FDA warning letter 94744 · New England District Office
Key facts
| Reference number | 94744 |
|---|---|
| Company | Braintree Laboratories Inc [ARCHIVED] |
| Subject | CGMP For Manfacturing, Processing, Packing, Storage & Holding/Adulterated |
| Issue date | May 10, 2010 |
| Posted date | May 10, 2010 |
| Issuing office | New England District Office |
| Product type | Drugs |
| CFR sections cited | 211.192 |
| Inspection city | Holbrook |
| Inspection ZIP | 02343 |
| Inspection start date | Dec 3, 2009 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: